Published in Medical Device Law Weekly, April 4th, 2010
15 percent over 2009 to approximately $56 million to $57.5 million,
and operating margin to be approximately 17 to 20 percent, excluding
litigation expense. Somanetics Corporation (NASDAQ:SMTS) reported net revenues of $13.1 million for the first quarter ended February 28, 2010, an 18 percent increase from $11.2 million in the same period of 2009....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.